Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B

Brain Research Bulletin

Volumn 56, Issue 5, 2001, Pages 453-462

  Holschneider, D P ^a,b   Chen, K ^c   Seif, I ^d   Shih, J C ^a,c,e  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CNRS   (France)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Dopamine; Monoamine oxidase; Norepinephrine; Phenylethylamine; Serotonin

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; DOPAMINE; NORADRENALIN; PHENETHYLAMINE; SEROTONIN;

BEHAVIOR; BIOCHEMISTRY; CONFERENCE PAPER; KNOCKOUT MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; CENTRAL NERVOUS SYSTEM; HUMANS; MICE, NEUROLOGIC MUTANTS; MONOAMINE OXIDASE; NEURONS; PHENOTYPE;

EID: 0035891881     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00613-X     Document Type: Conference Paper

References (89)

1. Effects of beta-phenylethylamine on locomotor activity, body temperature and ethanol blood concentrations during acute ethanol intoxication
2. cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties
3. In vivo release of endogenous dopamine, 5-hydroxytryptamine and some of their metabolites from rat caudate nucleus by phenylethylamine
4. Role of the serotonergic system in the forced swimming test
5. Is the forced swimming test a suitable model for revealing antidepressant activity?
6. Abnormal phrenic motoneuron activity and morphology in neonatal monoamine oxidase A-deficient transgenic mice: Possible role of a serotonin excess
7. Improvement of cognitive function by MAO-B inhibitor L-deprenyl in aged rats
8. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A
9. Species differences in the kinetics and metabolism of fenfluramine isomers
10. Selegiline versus L-acetylcarnitine in the treatment of Alzheimer-type dementia
11. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs
12. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA
13. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: Role of a serotonin excess during the critical period
14. Locomotor network maturation is transiently delayed in the MAOA-deficient mouse
15. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II
16. Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B
17. CSF 5-HIAA and family history of antisocial personality disorder in newborns
18. Effects of transient forebrain ischemia and pargyline on extracellular concentrations of dopamine, serotonin, and their metabolites in the rat striatum as determined by in vivo microdialysis
19. Effect of selective monoamine oxidase A and B inhibitors on footshock induced aggression in paired rats
20. Selegiline versus oxiracetam in patients with Alzheimer-type dementia
21. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist
22. Striatal dopamine metabolism in monoamine oxidase B-deficient mice: A brain dialysis study
23. Effects of acute and chronic administration of the antidepressants, imipramine, phenelzine and mianserin, on the social behaviour of mice
24. Chronic L-deprenyl or L-amphetamine: Equal cognitive enhancement, unequal MAO inhibition
25. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat
26. Human monoamine oxidase A and B genes exhibit identical exon-intron organization
27. Increased stress response and beta-phenylethylamine in MAOB-deficient mice
28. Lack of protection of monoamine oxidase B-deficient mice from age-related spatial learning deficits in the Morris water maze
29. Regional cerebral cortical activation in monoamine oxidase A-deficient mice: Differential effects of chronic versus acute elevations in serotonin and norepinephrine
30. Lack of protection from ischemic injury of monoamine oxidase B-deficient mice following middle cerebral artery occlusion
31. Steric requirements for catecholamine uptake by rat brain synaptosomes: Studies with rigid analogs of amphetamine
32. Monoamine oxidase B (MAOB)-containing structures in MAOA-deficient transgenic mice
33. Brain stem and spinal cord mediation of a serotonergic behavioral syndrome
34. Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: A biochemical assessment
35. Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice
36. Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain
37. Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase
38. Behavioral sensitization to beta-phenylethylamine (PEA): Enduring modifications of specific dopaminergic neuron systems in the rat
39. Effect of D-fenfluramine on serotonin release in brains of anaesthetized rats
40. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo
41. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with Norrie disease
42. Exogenous monoamines affect the segregation of retinogeniculate fibers in developing rats
43. Anxiogenic effect of phenylethylamine and amphetamine in the elevated plus-maze in mice and its attenuation by ethanol
44. Pharmacologic study of fenfluramine and its optical isomers
45. Transient uptake and storage of serotonin in developing thalamic neurons
46. Specific genetic deficiencies of the A and B isoenzymes of monoamine oxidase are characterized by distinct neurochemical and clinical phenotypes
47. Involvement of amygdala pathways in the influence of post-training intra-amygdala norepinephrine and peripheral epinephrine on memory storage
48. Homicide, suicide and CSF 5-HIAA
49. Central antiserotonin action of fluperlapine
50. Platelet and whole blood serotonin content in depressed inpatients: Correlations with acute and life-time psychopathology
51. Involvement of the amygdaloid complex in neuromodulatory influences on memory storage
52. Brain 5-HT and inhibition of aggressive behavior in animals: 5-HIAA and receptor subtypes
53. Whole blood serotonin relates to violence in an epidemiological study
54. Functional role of type I and type II interferons in antiviral defense
55. Are MAO-A deficiency states in the general population and in putative high-risk populations highly uncommon?
56. Marked amine and amine metabolite changes in Norrie disease patients with an X-chromosomal deletion affecting monoamine oxidase
57. Prenatal administration of para-chlorophenylalanine results in suppression of serotonergic system and disturbance of swimming movements in newborn rats
58. A simple assay for monoamine oxidase using glutathione peroxidase and glutathione reductase
59. Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase
60. Serotonin receptors and animal models of aggressive behavior
61. Selective and nonselective monoamine oxidase inhibitors: Behavioral disturbances during their administration to depressed patients
62. Plasma neurochemistry in juvenile offenders
63. Behavioral despair in mice: A primary screening test for antidepressants
64. Depression: A new animal model sensitive to antidepressant treatments
65. Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine
66. Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase
67. Monoamine oxidase A and B deficient mice exhibit altered baroreceptor reflexes
68. Excessive activation of 5-HT1B receptors disrupts the formation of sensory maps in monoamine oxidase A and 5-HT transporter knockout mice
69. Enhanced aggressive behavior in mice lacking 5-HT1B receptor
70. A pilot study of low-dose L-deprenyl in Alzheimer's disease
71. Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice
72. p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo
73. Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A
74. Hypothalamic monoamines measured by microdialysis in rats treated with 2-deoxy-glucose or d-fenfluramine
75. Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain
76. Monoamine oxidase deficiency in males with an X chromosome deletion
77. Ontogenesis of multiple forms of monoamine oxidase in rat brain regions and liver
78. Platelet serotonin measures in adolescents with conduct disorder
79. Excess of serotonin (5-HT) alters the segregation of ispilateral and contralateral retinal projections in monoamine oxidase A knock-out mice: Possible role of 5-HT uptake in retinal ganglion cells during development
80. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
81. Effects of monoamine oxidase A inhibition on barrel formation in the mouse somatosensory cortex: Determination of a sensitive developmental period
82. New perspectives on the functional organization and postsynaptic influences of the locus ceruleus efferent projection system
83. The distribution of neocortical projection neurons in the locus coeruleus
84. Effects of gestational exposure to monoamine oxidase inhibitors in rats: Preliminary behavioral and neurochemical studies
85. Antiserotonin activity of 9-methyl-2-[3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro- beta-carbolin-1-one (B-193)
86. Differences in somatosensory processing in S1 barrel cortex between normal and monoamine oxidase A knockout (Tg8) adult mice
87. The systemic administration of tacrine or selegiline facilitate spatial learning in aged fisher 344 rats
88. Aggressiveness of the rat following combined treatment with monomaime oxidase inhibitors and other psychotropic drugs, especially thymoleptics